Literature DB >> 27301717

Colorectal Cancer Statistics From the Veterans Affairs Central Cancer Registry.

Leah L Zullig1, Valerie A Smith2, George L Jackson2, Susanne Danus3, Merritt Schnell3, Jennifer Lindquist3, Dawn Provenzale4, Morris Weinberger3, Michael J Kelley5, Hayden B Bosworth6.   

Abstract

BACKGROUND: Colorectal cancer (CRC) is a common and potentially deadly disease. Although the United States has robust cancer data reporting, information from the Department of Veterans Affairs (VA) healthcare system has often been underrepresented in national cancer data sources. We describe veterans with incident CRC in terms of their patient and tumor characteristics and mortality. PATIENTS AND METHODS: Patients diagnosed or treated with CRC at any VA institution in the fiscal years 2009 to 2012 were identified using 3 data sources: (1) VA Central Cancer Registry (VACCR); (2) VA Corporate Data Warehouse; and (3) VA Reports and Measures Portal. The CRC frequencies within the VA population and survival curves were examined descriptively and compared with the national projections using Surveillance, Epidemiology, and End Results program data.
RESULTS: A total of 12,551 veterans with CRC were included in the present analysis. The median age at diagnosis was 65.5 years. Approximately 97% (n = 12,229) of the CRC cases were diagnosed among men. Approximately 44% (n = 5517) of the patients were diagnosed with localized disease. The 3-year survival rate was associated with age (P < .01) and stage (P < .01) at diagnosis. We identified a possible decrease in VA CRC incidence over time.
CONCLUSION: Although the VA CRC patient population was heavily skewed toward the male gender, the patient and tumor characteristics were similar between the incident CRC cases reported by the VACCR and those reported to the Surveillance, Epidemiology, and End Results program. This suggests that research findings resulting from the VACCR might have applicability beyond the VA healthcare system setting. Published by Elsevier Inc.

Entities:  

Keywords:  Colorectal; Incidence; Mortality; Neoplasms; U.S. Department of Veterans Affairs

Mesh:

Year:  2016        PMID: 27301717      PMCID: PMC5099105          DOI: 10.1016/j.clcc.2016.04.005

Source DB:  PubMed          Journal:  Clin Colorectal Cancer        ISSN: 1533-0028            Impact factor:   4.481


  19 in total

1.  Age adjustment using the 2000 projected U.S. population.

Authors:  R J Klein; C A Schoenborn
Journal:  Healthy People 2010 Stat Notes       Date:  2001-01

2.  Cancer incidence among patients of the U.S. Veterans Affairs Health Care System.

Authors:  Leah L Zullig; George L Jackson; Raye Anne Dorn; Dawn T Provenzale; Rebecca McNeil; Catherine M Thomas; Michael J Kelley
Journal:  Mil Med       Date:  2012-06       Impact factor: 1.437

3.  The impact of underreported Veterans Affairs data on national cancer statistics: analysis using population-based SEER registries.

Authors:  Nadia Howlader; Lynn A Ries; David G Stinchcomb; Brenda K Edwards
Journal:  J Natl Cancer Inst       Date:  2009-03-24       Impact factor: 13.506

4.  Colorectal cancer statistics, 2014.

Authors:  Rebecca Siegel; Carol Desantis; Ahmedin Jemal
Journal:  CA Cancer J Clin       Date:  2014-03-17       Impact factor: 508.702

5.  Health-related characteristics and dietary intakes of male veterans and non-veterans in the Multiethnic Cohort Study (United States).

Authors:  Song-Yi Park; Kangmin Zhu; John F Potter; Laurence N Kolonel
Journal:  J Mil Veterans Health       Date:  2011-04

6.  Impact of reporting delay and reporting error on cancer incidence rates and trends.

Authors:  Limin X Clegg; Eric J Feuer; Douglas N Midthune; Michael P Fay; Benjamin F Hankey
Journal:  J Natl Cancer Inst       Date:  2002-10-16       Impact factor: 13.506

7.  Are patients at Veterans Affairs medical centers sicker? A comparative analysis of health status and medical resource use.

Authors:  Z Agha; R P Lofgren; J V VanRuiswyk; P M Layde
Journal:  Arch Intern Med       Date:  2000-11-27

8.  Quality of nonmetastatic colorectal cancer care in the Department of Veterans Affairs.

Authors:  George L Jackson; L Douglas Melton; David H Abbott; Leah L Zullig; Diana L Ordin; Steven C Grambow; Natia S Hamilton; S Yousuf Zafar; Ziad F Gellad; Michael J Kelley; Dawn Provenzale
Journal:  J Clin Oncol       Date:  2010-06-01       Impact factor: 44.544

9.  Adjusting for reporting delay in cancer incidence when combining different sets of cancer registries.

Authors:  Lan Huang; Douglas Midthune; Martin Krapcho; Zhaohui Zou; Marie-Joseph Horner; Eric J Feuer
Journal:  Biom J       Date:  2013-07-19       Impact factor: 2.207

10.  Prevalence of overweight and obesity among U.S. military veterans.

Authors:  Nathaniel Almond; Leila Kahwati; Linda Kinsinger; Deborah Porterfield
Journal:  Mil Med       Date:  2008-06       Impact factor: 1.437

View more
  14 in total

1.  Cancer Incidence Among Patients of the U.S. Veterans Affairs Health Care System: 2010 Update.

Authors:  Leah L Zullig; Kellie J Sims; Rebecca McNeil; Christina D Williams; George L Jackson; Dawn Provenzale; Michael J Kelley
Journal:  Mil Med       Date:  2017-07       Impact factor: 1.437

2.  An RCT of Fecal Immunochemical Test Colorectal Cancer Screening in Veterans Without Recent Primary Care.

Authors:  Matthew A Goldshore; Shivan J Mehta; Woodrow Fletcher; George Tzanis; Chyke A Doubeni; E Carter Paulson
Journal:  Am J Prev Med       Date:  2020-07       Impact factor: 5.043

3.  Society for Surgery of the Alimentary Tract Health Care Quality and Outcomes Committee Webinar: Addressing Disparities.

Authors:  Gretchen C Edwards; Sandra L Wong; Maria C Russell; Emily R Winslow; Virginia O Shaffer; Timothy M Pawlik
Journal:  J Gastrointest Surg       Date:  2022-03-22       Impact factor: 3.452

4.  Comparison between Veteran and Non-Veteran Populations with Clinical Stage I Non-Small Cell Lung Cancer Undergoing Surgery.

Authors:  Brendan T Heiden; Daniel B Eaton; Su-Hsin Chang; Yan Yan; Martin W Schoen; Mayank R Patel; Daniel Kreisel; Ruben G Nava; Bryan F Meyers; Benjamin D Kozower; Varun Puri
Journal:  Ann Surg       Date:  2021-05-11       Impact factor: 12.969

5.  Targeting CDK7 increases the stability of Snail to promote the dissemination of colorectal cancer.

Authors:  Yan Zhou; Linlin Lu; Guanmin Jiang; Zhuojia Chen; Jiexin Li; Panpan An; Likun Chen; Jun Du; Hongsheng Wang
Journal:  Cell Death Differ       Date:  2018-11-19       Impact factor: 15.828

6.  Association of Health-Care System With Prostate Cancer-Specific Mortality in African American and Non-Hispanic White Men.

Authors:  Daniella Klebaner; P Travis Courtney; Isla P Garraway; John Einck; Abhishek Kumar; Maria Elena Martinez; Rana McKay; James D Murphy; Humberto Parada; Ajay Sandhu; Tyler Stewart; Kosj Yamoah; Brent S Rose
Journal:  J Natl Cancer Inst       Date:  2021-10-01       Impact factor: 11.816

7.  Meta-signature LncRNAs serve as novel biomarkers for colorectal cancer: integrated bioinformatics analysis, experimental validation and diagnostic evaluation.

Authors:  Meiyu Dai; Xiaoli Chen; Shanying Mo; Jinwan Li; Zhizhuo Huang; Shifeng Huang; Junyi Xu; Baoyu He; Yan Zou; Jingfan Chen; Shengming Dai
Journal:  Sci Rep       Date:  2017-04-13       Impact factor: 4.379

8.  Long Non-Coding RNA Reprogramming (ROR) Promotes Cell Proliferation in Colorectal Cancer via Affecting P53.

Authors:  Hong Li; Xiumei Jiang; Xuemei Niu
Journal:  Med Sci Monit       Date:  2017-02-20

Review 9.  Colorectal neoplasia differentially expressed: a long noncoding RNA with an imperative role in cancer.

Authors:  Meiyu Dai; Shan Li; Xue Qin
Journal:  Onco Targets Ther       Date:  2018-06-29       Impact factor: 4.147

10.  Cardiovascular disease-related chronic conditions among Veterans Affairs nonmetastatic colorectal cancer survivors: a matched case-control analysis.

Authors:  Leah L Zullig; Valerie A Smith; Jennifer H Lindquist; Christina D Williams; Morris Weinberger; Dawn Provenzale; George L Jackson; Michael J Kelley; Susanne Danus; Hayden B Bosworth
Journal:  Cancer Manag Res       Date:  2019-07-22       Impact factor: 3.989

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.